{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:25:32Z","timestamp":1769315132085,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF14CC0001"],"award-info":[{"award-number":["NNF14CC0001"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17OC0027594"],"award-info":[{"award-number":["NNF17OC0027594"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18SA0034956"],"award-info":[{"award-number":["NNF18SA0034956"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It is unknown how sequential drug patterns convey information on a patient\u2019s health status and treatment guidelines rarely account for this. Drug-agnostic longitudinal analyses of prescription trajectories in a population-wide setting are needed. In this cohort study, we used 24 years of data (1.1 billion prescriptions) from the Danish prescription registry to model the risk of sequentially redeeming a drug after another. Drug pairs were used to build multistep longitudinal prescription trajectories. These were subsequently used to stratify patients and calculate survival hazard ratios between the stratified groups. The similarity between prescription histories was used to determine individuals\u2019 best treatment option. Over the course of 122 million person-years of observation, we identified 9 million common prescription trajectories and demonstrated their predictive power using hypertension as a case. Among patients treated with agents acting on the renin-angiotensin system we identified four groups: patients prescribed angiotensin converting enzyme (ACE) inhibitor without change, angiotensin receptor blockers (ARBs) without change, ACE with posterior change to ARB, and ARB posteriorly changed to ACE. In an adjusted time-to-event analysis, individuals treated with ACE compared to those treated with ARB had lower survival probability (hazard ratio, 0.73 [95% CI, 0.64\u20130.82]; <jats:italic>P<\/jats:italic>\u2009&lt;\u20091\u2009\u00d7\u200910<jats:sup>\u221216<\/jats:sup>). Replication in UK Biobank data showed the same trends. Prescription trajectories can provide novel insights into how individuals\u2019 drug use change over time, identify suboptimal or futile prescriptions and suggest initial treatments different from first line therapies. Observations of this kind may also be important when updating treatment guidelines.<\/jats:p>","DOI":"10.1038\/s41746-021-00522-4","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T13:30:18Z","timestamp":1634736618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Optimizing drug selection from a prescription trajectory of one patient"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-223X","authenticated-orcid":false,"given":"Alejandro","family":"Aguayo-Orozco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7656-7976","authenticated-orcid":false,"given":"Amalie Dahl","family":"Haue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5694-4332","authenticated-orcid":false,"given":"Isabella Friis","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0128-8432","authenticated-orcid":false,"given":"David","family":"Westergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pope Lloyd","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-495X","authenticated-orcid":false,"given":"Laust Hvas","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0316-5866","authenticated-orcid":false,"given":"S\u00f8ren","family":"Brunak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"522_CR1","doi-asserted-by":"publisher","unstructured":"Organisation for Economic Co-operation and Development. OECD Health Statistics. 2019. https:\/\/doi.org\/10.1787\/health-data-en. Accessed June 2020.","DOI":"10.1787\/health-data-en"},{"key":"522_CR2","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1001\/jama.2017.16193","volume":"318","author":"AE Carroll","year":"2017","unstructured":"Carroll, A. E. The high costs of unnecessary care. JAMA 318, 1748\u20131749 (2017).","journal-title":"JAMA"},{"key":"522_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nbt.3180","volume":"33","author":"KD Mandl","year":"2015","unstructured":"Mandl, K. D. & Kohane, I. S. Federalist principles for healthcare data networks. Nat. Biotechnol. 33, 360\u2013363 (2015).","journal-title":"Nat. Biotechnol."},{"key":"522_CR4","doi-asserted-by":"crossref","unstructured":"Aanestad, M., Grisot, M., Hanseth, O. & Vassilakopoulou, P. Information Infrastructures within European Health Care: Working with the Installed Base (Springer, 2017).","DOI":"10.1007\/978-3-319-51020-0"},{"key":"522_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes, H. W., Sorensen, H. T. & Hallas, J. The Danish National Prescription Registry. Scand. J. Public Health 39, 38\u201341 (2011).","journal-title":"Scand. J. Public Health"},{"key":"522_CR6","first-page":"19","volume":"11","author":"T Klaukka","year":"2001","unstructured":"Klaukka, T. The Finnish database on drug utilisation. Nor. J. Epidemiol. 11, 19\u201322 (2001).","journal-title":"Nor. J. Epidemiol."},{"key":"522_CR7","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","volume":"48","author":"A Wolf","year":"2001","unstructured":"Wolf, A. et al. Data resource profile: clinical practice research datalink (CPRD) Aurum. Int. J. Epidemiol. 48, 1740\u2013174 (2001).","journal-title":"Int. J. Epidemiol."},{"key":"522_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44641-1","volume":"9","author":"A Sen","year":"2019","unstructured":"Sen, A. et al. Systematic assessment of prescribed medications and short-term risk of myocardial infarction\u2014a pharmacopeia-wide association study from Norway and Sweden. Sci. Rep. 9, 8257 (2019).","journal-title":"Sci. Rep."},{"key":"522_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41591-019-0503-6","volume":"25","author":"I Yelin","year":"2019","unstructured":"Yelin, I. et al. Personal clinical history predicts antibiotic resistance of urinary tract infections. Nat. Med. 25, 1143\u20131152 (2019).","journal-title":"Nat. Med."},{"key":"522_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48065-9","volume":"9","author":"T Jess","year":"2019","unstructured":"Jess, T. et al. Antibiotic use during pregnancy and childhood overweight: a population-based nationwide cohort study. Sci. Rep. 9, 11528 (2019).","journal-title":"Sci. Rep."},{"key":"522_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10914-6","volume":"10","author":"G Jordakieva","year":"2019","unstructured":"Jordakieva, G. et al. Country-wide medical records infer increased allergy risk of gastric acid inhibition. Nat. Commun. 10, 3298 (2019).","journal-title":"Nat. Commun."},{"key":"522_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep31308","volume":"6","author":"CJ Patel","year":"2016","unstructured":"Patel, C. J., Ji, J., Sundquist, J., Ioannidis, J. P. A. & Sundquist, K. Systematic assessment of pharmaceutical prescriptions in association with cancer risk: a method to conduct a population-wide medication-wide longitudinal study. Sci. Rep. 6, 31308 (2016).","journal-title":"Sci. Rep."},{"key":"522_CR13","doi-asserted-by":"publisher","first-page":"e191652","DOI":"10.1001\/jamasurg.2019.1652","volume":"154","author":"MI Sigurdsson","year":"2019","unstructured":"Sigurdsson, M. I. et al. Association between preoperative opioid and benzodiazepine prescription patterns and mortality after noncardiac surgery. JAMA Surg. 154, e191652 (2019).","journal-title":"JAMA Surg."},{"key":"522_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jbi.2014.09.003","volume":"53","author":"AP Wright","year":"2015","unstructured":"Wright, A. P., Wright, A. T., McCoy, A. B. & Sittig, D. F. The use of sequential pattern mining to predict next prescribed medications. J. Biomed. Inform. 53, 73\u201380 (2015).","journal-title":"J. Biomed. Inform."},{"key":"522_CR15","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.pain.2014.03.009","volume":"155","author":"OM Fredheim","year":"2014","unstructured":"Fredheim, O. M. et al. Chronic pain and use of opioids: a population-based pharmacoepidemiological study from the Norwegian prescription database and the Nord-Trondelag health study. Pain 155, 1213\u20131221 (2014).","journal-title":"Pain"},{"key":"522_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(20)30621-8","volume":"396","author":"NH Rod","year":"2020","unstructured":"Rod, N. H. et al. Trajectories of childhood adversity and mortality in early adulthood: a population-based cohort study. Lancet 396, 489\u2013497 (2020).","journal-title":"Lancet"},{"key":"522_CR17","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger, T. et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 75, 1334\u201313357 (2020).","journal-title":"Hypertension"},{"key":"522_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/bdi.12371","volume":"18","author":"LV Kessing","year":"2016","unstructured":"Kessing, L. V., Vradi, E. & Andersen, P. K. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord. 18, 174\u2013182 (2016).","journal-title":"Bipolar Disord."},{"key":"522_CR19","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","volume":"375","author":"AJ Webb","year":"2010","unstructured":"Webb, A. J., Fischer, U., Mehta, Z. & Rothwell, P. M. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 375, 906\u2013915 (2010).","journal-title":"Lancet"},{"key":"522_CR20","doi-asserted-by":"publisher","first-page":"e38909","DOI":"10.5812\/ircmj.38909","volume":"18","author":"A Aminzadeh","year":"2016","unstructured":"Aminzadeh, A., Sabeti Sanat, A. & Nik Akhtar, S. Frequency of candidiasis and colonization of Candida albicans in rRelation to oral contraceptive pills. Iran. Red. Crescent Med. J. 18, e38909 (2016).","journal-title":"Iran. Red. Crescent Med. J."},{"key":"522_CR21","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJMcp1503948","volume":"374","author":"AI Vinik","year":"2016","unstructured":"Vinik, A. I. Clinical practice. Diabetic sensory and motor neuropathy. N. Engl. J. Med. 374, 1455\u20131464 (2016).","journal-title":"N. Engl. J. Med."},{"key":"522_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S2213-8587(19)30310-9","volume":"7","author":"AJ Scheen","year":"2019","unstructured":"Scheen, A. J. SGLT2 inhibitor or GLP-1 receptor agonist in type 2 diabetes? Lancet Diabetes Endocrinol. 7, 818\u2013820 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"522_CR23","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/S2589-7500(19)30024-X","volume":"1","author":"AB Nielsen","year":"2019","unstructured":"Nielsen, A. B. et al. Survival prediction in intensive-care units based on aggregation of long-term disease history and acute physiology: a retrospective study of the Danish National Patient Registry and electronic patient records. Lancet Digital Health 1, e78\u2013e89 (2019).","journal-title":"Lancet Digital Health"},{"key":"522_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrg3208","volume":"13","author":"PB Jensen","year":"2012","unstructured":"Jensen, P. B., Jensen, L. J. & Brunak, S. Mining electronic health records: towards better research applications and clinical care. Nat. Rev. Genet. 13, 395\u2013405 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"522_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/520609a","volume":"520","author":"NJ Schork","year":"2015","unstructured":"Schork, N. J. Personalized medicine: time for one-person trials. Nature 520, 609\u2013611 (2015).","journal-title":"Nature"},{"key":"522_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/alz.12091","volume":"16","author":"IF Jorgensen","year":"2020","unstructured":"Jorgensen, I. F., Aguayo-Orozco, A., Lademann, M. & Brunak, S. Age-stratified longitudinal study of Alzheimer\u2019s and vascular dementia patients. Alzheimers Dement. 16, 908\u2013917 (2020).","journal-title":"Alzheimers Dement."},{"key":"522_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18682-4","volume":"11","author":"T Siggaard","year":"2020","unstructured":"Siggaard, T. et al. Disease trajectory browser for exploring temporal, population-wide disease progression patterns in 7.2 million Danish patients. Nat. Commun. 11, 4952 (2020).","journal-title":"Nat. Commun."},{"key":"522_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jash.2010.03.001","volume":"4","author":"AH Gradman","year":"2010","unstructured":"Gradman, A. H., Basile, J. N., Carter, B. L. & Bakris, G. L., American Society of Hypertension Writing Group. Combination therapy in hypertension. J. Am. Soc. Hypertens. 4, 90\u201398 (2010).","journal-title":"J. Am. Soc. Hypertens."},{"key":"522_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jadohealth.2013.12.006","volume":"55","author":"EY Yoon","year":"2014","unstructured":"Yoon, E. Y. et al. Use of antihypertensive medications and diagnostic tests among privately insured adolescents and young adults with primary versus secondary hypertension. J. Adolesc. Health 55, 73\u201378 (2014).","journal-title":"J. Adolesc. Health"},{"key":"522_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCRESAHA.118.313294","volume":"124","author":"G Mancia","year":"2019","unstructured":"Mancia, G., Rea, F., Corra, G. & Grassi, G. Two-drug combinations as first-step antihypertensive treatment. Circ. Res. 124, 1113\u20131123 (2019).","journal-title":"Circ. Res."},{"key":"522_CR31","unstructured":"WHO. Prevention of Cardiovascular Disease. Guidelines for Assessment and Management of Cardiovascular Risk (WHO, 2007)."},{"key":"522_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen, C. B. The Danish civil registration system. Scand. J. Public Health 39, 22\u201325 (2011).","journal-title":"Scand. J. Public Health"},{"key":"522_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373\u2013383 (1987).","journal-title":"J. Chronic Dis."},{"key":"522_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-021-00382-y","volume":"4","author":"IF Jorgensen","year":"2021","unstructured":"Jorgensen, I. F. & Brunak, S. Time-ordered comorbidity correlations identify patients at risk of mis- and overdiagnoses. npj Digit. Med. 4, 1\u201310 (2021).","journal-title":"npj Digit. Med."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00522-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:09:13Z","timestamp":1677110953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00522-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1038\/s41746-021-00522-4","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.B. reports ownerships in Intomics A\/S, Hoba Therapeutics Aps, Novo Nordisk A\/S, Lundbeck A\/S, and managing board memberships in Proscion A\/S and Intomics A\/S outside the submitted work. A.A.O., A.D.H., I.F.J., D.W., P.M., and L.V.M. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}